Pennsylvania House Approves Hospital Cannabis Access for Terminal Patients
Pennsylvania advances legislation allowing terminally ill patients to use medical marijuana in hospitals, expanding access within existing framework.
The Pennsylvania House of Representatives passed legislation Monday expanding medical cannabis access for terminally ill patients within hospital settings. House Bill 2254, sponsored by Rep. Dan Frankel, passed with overwhelming bipartisan support in a 174-27 vote and now advances to the state Senate for consideration.
The measure addresses a critical gap in Pennsylvania's existing medical marijuana program by explicitly permitting cannabis use in hospitals and healthcare facilities for patients with terminal diagnoses. Current state law creates ambiguity around medical cannabis consumption in hospital settings, often forcing patients to choose between their prescribed cannabis treatments and inpatient care.
Pennsylvania's medical marijuana market generated over $650 million in sales during 2023, making it one of the largest limited-license medical programs in the United States. The state currently operates 23 licensed cultivators and processors serving approximately 450,000 registered patients through nearly 200 dispensary locations statewide.
This legislative development reflects broader national momentum toward expanding medical cannabis access within healthcare institutions. Similar hospital access provisions have gained traction across multiple states as medical professionals increasingly recognize cannabis as legitimate palliative care. The American Nurses Association and several state medical associations have endorsed hospital cannabis access policies for terminally ill patients.
The bill's passage timing coincides with ongoing federal discussions around cannabis rescheduling, which could further legitimize medical marijuana use in federally funded healthcare facilities. Pennsylvania's action demonstrates how state-level policy continues driving cannabis normalization even amid federal regulatory uncertainty, potentially creating templates for other medical marijuana states to expand patient access within institutional healthcare settings.